A Business at a Glance
0 of 1 daily views used (1 remaining). Sign up free for +5 more daily views (6 total), or try AAPL for a full preview.
ULTRALIFE CORP
ULBI
$88M
Mkt Cap
$5.30
-1.49%
ULTRALIFE CORP (ULBI) has a current P/E ratio of 53.0, compared to its historical median P/E of 19.2. The stock is currently considered Expensive based on its historical valuation range.
ULTRALIFE CORP (ULBI) has a 5-year average return on invested capital (ROIC) of 2.7%. This is below average and may indicate limited pricing power.
ULTRALIFE CORP (ULBI) has a market capitalization of $88M. It is classified as a small-cap stock.
ULTRALIFE CORP (ULBI) does not currently pay a regular dividend.
Based on historical P/E analysis, ULTRALIFE CORP (ULBI) appears expensive. The current P/E of 53.0 is 176% above its historical median of 19.2. The estimated fair value CAGR (P/E method) is -52.0%.
ULTRALIFE CORP (ULBI) operates in the Miscellaneous Electrical Machinery, Equipment & Supplies industry, within the Technology sector.
ULTRALIFE CORP (ULBI) reported annual revenue of $191 million in its most recent fiscal year, based on SEC EDGAR filings.
ULTRALIFE CORP operates in the Miscellaneous Electrical Machinery, Equipment & Supplies industry, Technology sector. Full business description from SEC filing not yet available.
| Metric | TTM | FY2025 | FY2024 | FY2023 | FY2022 | FY2021 |
|---|---|---|---|---|---|---|
| Revenue | 191M | 191M | 164M | 159M | 132M | 98M |
| Net Income | 0 | - | - | 7.2M | -119K | -234K |
| EPS | $-35.00 | $-35.00 | $38.00 | $0.44 | $-0.01 | $-0.01 |
| Free Cash Flow | 7.1M | 7.1M | 15M | -623K | -2.9M | 1.5M |
| ROIC | -2.7% | - | - | 5.4% | - | 0.0% |
| Gross Margin | 24.1% | 24.1% | 25.7% | 24.7% | 22.3% | 25.1% |
| Debt/Equity | 0.41 | 0.41 | 0.44 | 0.23 | 0.18 | 0.18 |
| Dividends/Share | $0.00 | $0.00 | - | - | - | - |
| Operating Income | -5.9M | -5.9M | 10.0M | 9.5M | - | 35K |
| Operating Margin | -3.1% | -3.1% | 6.1% | 6.0% | - | 0.0% |
| ROE | 0.0% | - | - | 6.0% | -0.1% | -0.2% |
| Shares Outstanding | 17M | 17M | 17M | 16M | 16M | 16M |
| Metric | |||||||||||||
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Income Statement | |||||||||||||
| Revenue | 66M | 76M | 82M | 86M | 87M | 107M | 108M | 98M | 132M | 159M | 164M | 191M | 191M |
| Gross Margin | 29.1% | 30.5% | 30.4% | 30.7% | 29.3% | 29.2% | 27.1% | 25.1% | 22.3% | 24.7% | 25.7% | 24.1% | 24.1% |
| R&D | 5.3M | 5.6M | 5.9M | 4.7M | 4.5M | 6.8M | 5.9M | 6.8M | 7.1M | 7.5M | 8.3M | 10M | 10M |
| SG&A | 15M | 14M | 15M | 15M | 15M | 17M | 18M | 18M | 22M | 22M | 24M | 29M | 29M |
| EBIT | -1.4M | 3.3M | 3.8M | 6.5M | 6.6M | 7.4M | 5.7M | 35K | N/A | 9.5M | 10.0M | -5.9M | -5.9M |
| Op. Margin | -2.2% | 4.4% | 4.6% | 7.6% | 7.5% | 6.9% | 5.3% | 0.0% | N/A | 6.0% | 6.1% | -3.1% | -3.1% |
| Net Income | -2.1M | 2.9M | 3.5M | 7.6M | 25M | N/A | 5.2M | -234K | -119K | 7.2M | N/A | N/A | 0 |
| Net Margin | -3.2% | 3.8% | 4.3% | 8.9% | 28.6% | N/A | 4.9% | -0.2% | -0.1% | 4.5% | N/A | N/A | 0.0% |
| Non-Recurring | 459K | -114K | -29K | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Returns on Capital | |||||||||||||
| ROIC | -2.9% | 5.7% | 6.7% | 10.9% | 27.1% | N/A | 3.8% | 0.0% | N/A | 5.4% | N/A | N/A | -2.7% |
| ROE | -2.9% | 4.2% | 5.2% | 10.4% | 27.1% | N/A | 4.6% | -0.2% | -0.1% | 6.0% | N/A | N/A | 0.0% |
| ROA | -2.4% | 3.4% | 4.2% | 8.4% | 22.9% | N/A | 3.7% | -0.2% | -0.1% | 4.2% | N/A | N/A | 0.0% |
| Cash Flow | |||||||||||||
| Op. Cash Flow | 3.7M | 8.6M | 7.7M | 7.3M | 11M | -3.0M | 22M | 4.3M | -1.3M | 1.9M | 17M | 11M | 11M |
| Free Cash Flow | 2.0M | 5.6M | 6.4M | 5.9M | 6.7M | -9.3M | 19M | 1.5M | -2.9M | -623K | 15M | 7.1M | 7.1M |
| Owner Earnings | -166K | 5.5M | 4.2M | 4.2M | 7.6M | -6.5M | 18M | 115K | -6.5M | -2.5M | 12M | 4.6M | 4.6M |
| CapEx | 1.7M | 2.9M | 1.2M | 1.4M | 4.2M | 6.3M | 3.1M | 2.8M | 1.7M | 2.6M | 1.9M | 3.9M | 3.9M |
| Maint. CapEx | 2.8M | 2.5M | 2.7M | 2.4M | 2.4M | 2.7M | 2.9M | 3.5M | 4.5M | 3.9M | 4.2M | 5.5M | 5.5M |
| Growth CapEx | 0 | 438K | 0 | 0 | 1.8M | 3.5M | 166K | 0 | 0 | 0 | 0 | 0 | 0 |
| D&A | 2.8M | 2.5M | 2.7M | 2.4M | 2.4M | 2.7M | 2.9M | 3.5M | 4.5M | 3.9M | 4.2M | 5.5M | 5.5M |
| CapEx/OCF | 45.1% | 34.0% | 15.9% | N/A | 38.4% | N/A | 14.3% | 65.1% | N/A | 132.3% | 11.6% | N/A | 35.2% |
| Capital Allocation | |||||||||||||
| Dividends Paid | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Dividend Yield | N/A | N/A | N/A | N/A | N/A | N/A | N/A | N/A | N/A | N/A | N/A | N/A | N/A |
| Share Buybacks | 0 | 9.4M | 607K | 0 | 742K | 2.0M | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Buyback Yield | N/A | N/A | 0.8% | 0.0% | 0.7% | 1.7% | N/A | N/A | N/A | N/A | N/A | 0.0% | 0.0% |
| Stock-Based Comp | 1.0M | 571K | 710K | 653K | 890K | 753K | 943K | 671K | 776K | 528K | 698K | 935K | 935K |
| Debt Repayment | 0 | 0 | 3.0M | 0 | 0 | 157K | 0 | 114K | 100K | 0 | 1.4M | 24K | 24K |
| Balance Sheet | |||||||||||||
| Net Debt | -18M | -14M | -11M | N/A | -25M | 12M | -9.2M | 13M | 16M | 19M | 52M | 44M | 44M |
| Cash & Equiv. | 18M | 14M | 11M | 18M | 26M | 7.1M | 11M | 8.3M | 5.6M | 10M | 6.9M | 9.3M | 9.3M |
| Long-Term Debt | N/A | N/A | N/A | N/A | N/A | 16M | 0 | 19M | 19M | 24M | 52M | 46M | 46M |
| Debt/Equity | 0.00 | 0.00 | 0.00 | 0.23 | 0.01 | 0.17 | 0.01 | 0.18 | 0.18 | 0.23 | 0.44 | 0.41 | 0.41 |
| Interest Coverage | -6.6 | 13.4 | 14.3 | 35.4 | 104.0 | 13.7 | 13.1 | 0.1 | N/A | 4.7 | 5.1 | -1.5 | -1.5 |
| Equity | 72M | 66M | 68M | 79M | 105M | 110M | 117M | 118M | 116M | 125M | 134M | 130M | 130M |
| Total Assets | 88M | 82M | 85M | 97M | 121M | 145M | 138M | 160M | 168M | 178M | 220M | 217M | 217M |
| Total Liabilities | 16M | 16M | 17M | 18M | 16M | 35M | 21M | 42M | 52M | 53M | 86M | 87M | 87M |
| Intangibles | 4.3M | 3.9M | 7.2M | 7.1M | 6.5M | 9.7M | 9.2M | 17M | 16M | 15M | 25M | 11M | 11M |
| Retained Earnings | -97M | -94M | -91M | -83M | -58M | -53M | -48M | -48M | -48M | -41M | -34M | -40M | -40M |
| Working Capital | 46M | 41M | 38M | 48M | 52M | 53M | 46M | 48M | 50M | 66M | 68M | 68M | 68M |
| Current Assets | 57M | 52M | 49M | 62M | 67M | 70M | 64M | 67M | 79M | 90M | 97M | 106M | 106M |
| Current Liabilities | 11M | 11M | 11M | 14M | 15M | 17M | 19M | 19M | 29M | 24M | 29M | 37M | 37M |
| Per Share Data | |||||||||||||
| EPS | -0.12 | 0.17 | 0.23 | 0.48 | 1.53 | 32.00 | 0.33 | -0.01 | -0.01 | 0.44 | 38.00 | -35.00 | -35.00 |
| Owner EPS | -0.01 | 0.33 | 0.28 | 0.26 | 0.47 | -0.41 | 1.13 | 0.01 | -0.40 | -0.15 | 0.71 | 0.27 | 0.27 |
| Book Value | 4.08 | 3.92 | 4.46 | 4.97 | 6.42 | 6.92 | 7.37 | 7.29 | 7.11 | 7.66 | 8.06 | 7.80 | 7.80 |
| Cash Flow/Share | 0.21 | 0.51 | 0.50 | 0.46 | 0.67 | -0.19 | 1.37 | 0.27 | -0.08 | 0.12 | 1.00 | 0.66 | 0.33 |
| Dividends/Share | N/A | N/A | N/A | 0.00 | N/A | N/A | N/A | N/A | N/A | N/A | N/A | 0.00 | 0.00 |
| Shares Out. | 17.6M | 16.9M | 15.3M | 15.9M | 16.3M | 15.9M | 15.9M | 16.1M | 16.3M | 16.4M | 16.6M | 16.7M | 16.7M |
| Valuation | |||||||||||||
| P/E Ratio | N/A | 34.8 | 20.7 | N/A | 4.4 | 0.2 | 19.2 | 123.2 | 74.0 | 16.0 | 19.2 | N/A | -0.2 |
| P/FCF | 26.6 | 19.5 | 11.3 | N/A | 16.5 | N/A | 5.4 | 65.8 | N/A | N/A | 8.2 | N/A | 12.4 |
| EV/EBIT | N/A | N/A | N/A | N/A | N/A | 18.1 | 17.9 | N/A | 162.4 | 14.8 | 17.6 | N/A | N/A |
| Price/Book | 0.6 | 1.5 | 1.1 | N/A | 1.1 | 1.1 | 0.9 | 0.8 | 0.5 | 0.9 | 0.9 | N/A | 0.7 |
| Price/Sales | 0.8 | 0.9 | 0.9 | N/A | 1.6 | 1.3 | 1.0 | 1.2 | 0.6 | 0.6 | 0.9 | N/A | 0.5 |
| FCF Yield | 4.3% | 5.6% | 8.9% | N/A | 6.1% | -8.0% | 18.5% | 1.5% | -4.8% | -0.5% | 12.1% | N/A | 8.1% |
| Market Cap | 47M | 100M | 72M | 0 | 110M | 116M | 101M | 99M | 61M | 115M | 121M | 0 | 88M |
| Avg. Price | 3.54 | 4.63 | 4.77 | 0.00 | 8.49 | 8.72 | 6.76 | 7.47 | 4.93 | 6.13 | 9.35 | 0.00 | 5.30 |
| Year-End Price | 3.04 | 6.52 | 4.75 | 0.00 | 6.77 | 7.29 | 6.34 | 6.16 | 3.70 | 7.03 | 7.29 | 0.00 | 5.30 |
ULTRALIFE CORP passes 0 of 9 quality checks, indicating weak fundamentals.
ULTRALIFE CORP trades at 53.0x trailing earnings, compared to its 15-year median P/E of 19.2x, suggesting it is currently Expensive relative to its historical range. On a free-cash-flow basis, the stock trades at 9.9x vs a median of 11.3x. The company's 5-year average ROIC is 2.7% with a gross margin of 24.4%. At current prices, the estimated annualized return to fair value is -9.1%.
ULTRALIFE CORP (ULBI) generated $7 million in free cash flow in its most recent fiscal year. Positive free cash flow supports dividends, buybacks, and debt reduction.
ULTRALIFE CORP (ULBI) has a debt-to-equity ratio of 0.41. This indicates a conservatively financed balance sheet.
ULTRALIFE CORP (ULBI) reported earnings per share (EPS) of $-35.00 in its most recent fiscal year.
ULTRALIFE CORP (ULBI) has a 5-year average gross margin of 24.4%. This lower margin is typical of capital-intensive or commodity businesses.
The Ledger Terminal provides 15 years of financial data for ULTRALIFE CORP (ULBI), sourced directly from SEC EDGAR filings. This includes income statements, balance sheets, cash flow statements, and key financial ratios.
ULTRALIFE CORP (ULBI) has a book value per share of $7.80, based on its most recent annual SEC filing.
No recent press releases.